Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2003-11-07
2010-10-26
Chen, Stacy B (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S199100
Reexamination Certificate
active
07820182
ABSTRACT:
Chimeric human-bovine respiratory syncytial virus (RSV) are infectious and attenuated in humans and other mammals and useful in immunogenic compositions for eliciting an anti-RSV immune response. Also provided are isolated polynucleotide molecules and vectors incorporating a chimeric RSV genome or antigenome which includes a partial or complete human or bovine RSV “background” genome or antigenome combined or integrated with one or more heterologous gene(s) or genome segment(s) of a different RSV strain. Chimeric human-bovine RSV of the invention include a partial or complete “background” RSV genome or antigenome derived from or patterned after a human or bovine RSV strain or subgroup virus combined with one or more heterologous gene(s) or genome segment(s) of a different RSV strain or subgroup virus to form the human-bovine chimeric RSV genome or antigenome. In preferred aspects of the invention, chimeric RSV incorporate a partial or complete bovine RSV background genome or antigenome combined with one or more heterologous gene(s) or genome segment(s) from a human RSV. Genes of interest include any of the NS1, NS2, N, P, M, SH, M2(ORF1), M2(ORF2), L, F or G genes or a genome segment including a protein or portion thereof. A variety of additional mutations and nucleotide modifications are provided within the human-bovine chimeric RSV of the invention to yield desired phenotypic and structural effects.
REFERENCES:
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis et al.
patent: 4800078 (1989-01-01), Prince et al.
patent: 5922326 (1999-07-01), Murphy et al.
patent: 5993824 (1999-11-01), Murphy et al.
patent: 6264957 (2001-07-01), Collins et al.
patent: 6689367 (2004-02-01), Collins et al.
patent: WO-97/06270 (1997-02-01), None
patent: WO-98/02530 (1998-01-01), None
patent: WO-98/53078 (1998-11-01), None
Collins et al., (1995) PNAS USA 92:11563-11567.
Tang et al ., (2001) Journal of Virology, 75:11328-11335.
Ahmadian et al., Expression of the ORF-2 Protein of the Human Respiratory Syncytial Virus M2 Gene, EMBO Journal vol. 19, 2681-2689 (2000).
Anderson et al., Antigenic Characterization of Respiratory Syncytial Virus Strains With Monoclonal Antibodies, Journal of Infectious Diseases, vol. 151, No. 4, 626-633 (1985).
Atreya et al., The NS1 Protein of Human Respiratory Syncytial Virus Is a Potent Inhibitor of Minigenome Transcription and RNA Replication, Journal of Virology, vol. 72, 1452-1461 (1998).
Bailly et al., A Recombinant Human Parainfluenza Virus Type 3 (PIV3) in Which the Nucleocapsid N Protein Has Been Replaced, Journal of Virology, vol. 74, No. 7, 3188-3195 (2000).
Baron et al., Rescue of Rinderpest Virus From Cloned cDNA, Journal of Virology, vol. 71, No. 2, 1265-1271 (1997).
Belshe et al., Evaluation of Five Temperature-Sensitive Mutants of Respiratory Syncytial Virus in Primates, Journal of Medical Virology, vol. 3, 101-110 (1978).
Belshe et al., Experimental Respiratory Syncytial Virus Infection of Four Species of Primates, Journal of Medical Virology, vol. 1, 157-162 (1977).
Bermingham et al., the M2-2 Protein of Human Respiratory Syncytial Virus, Proc. Natl. Acad. Sci., vol. 96, 11259-11264 (1999).
Buchholz et al., Chimeric Bovine Respiratory Syncytial Virus With Glycoprotein Gene Substitutions, Journal of Virology, vol. 74, No. 3, 1187-1199 (2000).
Buchholz et al., Generation of Bovine Respiratory Syncytial Virus (BRSV) from cDNA, Journal of Virology, vol. 73, No. 1, 251-259 (1999).
Bukreyev et al., Interferon Gamma Expressed by a Recombinant Respiratory Syncytial Virus, Proc. Natl. Acad. Sci., vol. 96, 2367-2372 (1999).
Bukreyev et al., Recombinant Respiratory Syncytial Virus From Which Entire SH Gene Deleted Grows in Cell Culture, Journal of Virology, vol. 71, No. 12, 8973-8982 (1997).
Bukreyev et al., Recovery of Infectious Respiratory Syncytial Virus Expressing An Additional, Foreign Gene, Journal of Virology, vol. 70, No. 10, 6634-6641 (1996).
Cahour et al., Growth-Restricted Dengue Virus Mutants Containing Deletions in the 5 Noncoding Region of the RNA Genome, Virology, vol. 207, 68-76 (1995).
Cheng et al., Effective Amplification of Long Targets From Cloned Inserts and Human Genomic DNA, Proc. Natl. Acad. Sci., vol. 91, 5695-5699 (1994).
Chin et al., Field Evaluation of a Respiratory Syncytial Virus Vaccine and a Trivalent Parainfluenza Virus Vaccine in a Pediatric Population, American Journal of Epidemiology, vol. 89, 449-463 (1968).
Clements et al., Evaluation of Bovine Cold-Adapted Human, and Wild-Type Human Parainfluenza Type 3 Viruses in Adult Volunteers, Journal of Clinical Microbiology, vol. 29, 1175-1182 (1991).
Collins et al., Rational Design of Live Attenuated Recombinant Vaccine Virus for Human Respiratory Syncytial Virus by Reverse Genetics, Advanced Virus Research, vol. 54, 423-451 (1999).
Collins et al., Envelope-Associated 22K Protein of Human Respiratory Syncytial Virus, Journal of Virology, vol. 54, No. 1, 65-71 (1985).
Collins et al., Nucleotide Sequences for the Gene Junction of Human Respiratory Syncytial Virus Reveal, Proc. Natl. Acad. Sci., vol. 83, 4594-4598 (1986).
Collins et al., Gene Overlap and Site Specific Attenuation of Transcription, Proc. Natl. Acad. Sci., vol. 84, 5134-5138 (1987).
Collins et al., Transcription Elongation of Respiratory Syncytial Virus a Nonsegmented Negative-Strand RNA Virus, Proc. Natl. Acad. Sci., vol. 93, 81-85 (1996).
Collins et al., Production of Infectious Human Respiratory Syncytial Virus From Cloned cDNA, Pro. Natl. Acad. Sci., vol. 92, 11563-11567 (1995).
Collins et al., Respiratory Syncytial Virus, Fields Virology, Second Ed., 1313-1352, (1996).
Collins et al., Support Plasmids and Support Proteins Required for Recovery of Recombinant Respiratory Syncytial Virus, Virology, vol. 259, 251-255 (1999).
Collins et al., Two Open Reading Frames of 22K mRNA of Human Respiratory Syncytial Virus, Journal of General Virology, vol. 71, 3015-3020 (1990).
Collins et al., Evaluation in Chimpanzees of Vaccinia Virus Recombinants That express the Surface, Vaccine, vol. 8, 164-168 (1990).
Connors et al., A Cold Passaged Attenuated Strain of Human Respiratory Syncytial Virus Contains Mutations in the F and L Genes, Virology, vol. 208, 478-484 (1995).
Connors et al., Respiratory Syncytial Virus (RSV) F, G, M2 (22K), and N Proteins Each Induce Resistance to RSV Challenge, Journal of Virology. vol. 65(3), 1634-1637 (1991).
Connors et al., Resistance to Respiratory Syncytial Virus (RSV), Journal of Virology, vol. 66, No. 2, 1277-1281 (1992).
Conzelmann et al., Genetic Manipulation of Non-Segmented Negative-Strand RNA Viruses, Journal of General Virology, vol. 77, 381-389 (1996).
Corsaro et al., Enhancing the Efficiency of DNA Mediated Gene Transfer in Mammalian Cells, Somatic Cell Genetics, vol. 7, 603-616 (1981).
Crowe et al., A Comparison in Chimpanzees of Immunogenic Efficacy of Live Attenuated Respiratory Syncytial Virus (RSV), Vaccine, vol. 11, Issue 14, 1395-1404 (1993).
Crowe et al., A Further Attenuated Derivative of Cold-Passaged Temperature-Sensitive Mutant of Human Respiratory Syncytial Virus, Vaccine, vol. 12, No. 9, 783-790 (1994).
Crowe et al., Satisfactorily Attenuated Protective Mutants Derived From Partially Attenuated Cold Passaged Respiratory Syncytial Virus, Vaccine, vol. 12, No. 8, 691-699 (1994).
Durbin et al., Recovery of Infections Human Parainfluenza Virus Type 3 from cDNA, Virology, vol. 235, 323-332 (1997).
Emerson et al., A Simian Strain of Hepatitis A Virus, AGM-27, Functions As an Attenuated Vaccine for Chimpanzees, Journal of Infectious Diseases, vol. 173, 592-597 (1996).
Falsey, et al., Respiratory Syncytial Virus and Influenza A Infections in the Hospitalized Elderly, Journal of Infectious Diseases, vol. 172, 389-394 (1995).
Fernie & Gerin, The Stabilization and Purification of Respiratory Syncytial Virus Using MgSO4, Virology, vol. 106, 141-144 (1980).
Fouillard et al., Severe Respiratory Syncytial Virus Pneumonia After Autologous Bone Marrow Transplantation: A Report of Three Cases Review, Bone Marrow Transplant, vol. 9
Buchholz Ursula
Collins Peter L.
Krempl Christine D.
Murphy Brian R.
Whitehead Stephen S.
Chen Stacy B
The United States of America as represented by the Department of
Woodcock & Washburn LLP
LandOfFree
Production of attenuated, human-bovine chimeric respiratory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Production of attenuated, human-bovine chimeric respiratory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of attenuated, human-bovine chimeric respiratory... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4156671